article thumbnail

Cardiometabolic Health Congress (CMHC) will present the results of a webcast series designed to help practitioners improve patient care

Cardiometabolic Health Congress

As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.

article thumbnail

Engaging Primary Care Clinicians in Screening for Hypercortisolism

HCPLive

Medical experts explore why findings from this study are crucial for clinicians managing diabetes, particularly those in primary care settings, and how these insights can impact their approach to patient care.

article thumbnail

The New Era of Continuous Glucose Monitoring (CGM) Expanding Access and Improving Outcomes

Cardiometabolic Health Congress

Recent over-the-counter (OTC) approvals for CGM systems are transforming diabetes management and lifestyle management for those without diabetes, making this an exciting time for healthcare professionals and their patients. This leads to better patient engagement and, ultimately, better health outcomes.

article thumbnail

Compassionate Care to Improve Patient Outcomes and Your Career from EMU 2024

ECG Cases

A cultural shift emphasizing the importance of compassion in patient care needs to occur to improve outcomes of our patients and our job satisfaction; as such, compassion should be part of our training and CME. Compassion in not simply innate; like any behaviour, it can be learned through deliberate practice.

CME 52
article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

article thumbnail

A Practical Guide to Understanding and Treating Peripheral Artery Disease

Journal of Cardiovascular Pharmacology

Treatment of risk factors such as diabetes and cigarette smoking can benefit patients with PAD. Patients should have adequate blood pressure and lipid control to decrease clinical manifestations and symptoms of PAD. Treatment of risk factors such as diabetes and cigarette smoking can benefit patients with PAD.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. One promising strategy is the formation of creative partnerships between patients and their healthcare teams.